Post-Traumatic Stress Disorder (PTSD) affects 1 in 5 of our returning veterans. This presentation is a literature review designed to discuss both the epidemiology of PTSD and the evolving treatment methods available in the military and civilian sectors. For many years, anxiolytic medications have been considered the 'gold standard' treatment option for PTSD.However, new research demonstrates poor patient outcomes and challenges the role of prescription medications in the treatment of PTSD.It ispertinentthat medical professionals understand and incorporateappropriate resources in order to improve the quality of life for veterans who are surviving with PTSD.
